Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review
Shuang Luo, Yu Jiang, Anfu Zheng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18

Showing 18 citing articles:

Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation
Reem Qannita, Ayah Alalami, Amani A. Harb, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 195-195
Open Access | Times Cited: 40
Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment
Shijiao Zhi, Chen Chen, Hanlin Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
The intersection of the nervous system and breast cancer
Yutong Liu, Shiqi Yin, Guanyu Lu, et al.
Cancer Letters (2024) Vol. 598, pp. 217132-217132
Closed Access | Times Cited: 13
Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 234-234
Open Access | Times Cited: 1
Biomimetic liposomal nanozymes improve breast cancer chemotherapy with enhanced penetration and alleviated hypoxia
Juanjuan Li, Chunai Gong, Xinlu Chen, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Metabolic reprogramming induced by PSMA4 overexpression facilitates bortezomib resistance in multiple myeloma
Han Y, Chengli Wu, Jie He, et al.
Annals of Hematology (2025)
Open Access
Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes
Rhuthuparna Malayil, Yogita Chhichholiya, Kanika Vasudeva, et al.
Medical Oncology (2023) Vol. 40, Iss. 6
Closed Access | Times Cited: 9
Hybrid computational modeling highlights reverse warburg effect in breast cancer-associated fibroblasts
Sahar Aghakhani, Sacha E Silva-Saffar, Sylvain Soliman, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 4196-4206
Open Access | Times Cited: 6
The signature of extracellular vesicles in hypoxic breast cancer and their therapeutic engineering
Beiqing Zhu, Kehao Xiang, Tanghua Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
ROLE OF HYPOXIA INDUCIBLE FACTOR-1? IN LYMPH NODE METASTASIS OF BREAST CANCER
Galuh Widowati
Berkala Ilmiah Kedokteran Duta Wacana (2024) Vol. 9, Iss. 2
Closed Access | Times Cited: 1
Potential anti-cancer activity of Moringa oleifera derived bio-active compounds targeting hypoxia-inducible factor-1 alpha in breast cancer
Neha Masarkar, Suman Kumar Ray, Zirha Saleem, et al.
Journal of Complementary and Integrative Medicine (2023) Vol. 21, Iss. 3, pp. 282-294
Closed Access | Times Cited: 3
The Interplay Between HIF‐1α and EZH2 in Lung Cancer and Dual‐Targeted Drug Therapy
Jianmin Wang, Cheng Yang, Huashen Xu, et al.
Advanced Science (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 3
Comparative morphology of tumour microenvironment in claudin-low and claudin-high breast cancers
Reena Yadav, Aditti Sharma, Divya Dahiya, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155502-155502
Closed Access
Comprehensive review of perioperative factors influencing ferroptosis
Cheng-Hui Fan, Xiaoqin Zeng, Rui-Min Feng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117375-117375
Open Access
Challenges and Recent Advances in Erythropoietin Stability.
Bahgat Fayed, Shanshan Luo, Alaa Eldeen B. Yassin
Pharmaceutical Development and Technology (2024), pp. 1-15
Closed Access
Targeting PGK1: A New Frontier in Breast Cancer Therapy Under Hypoxic Conditions
Jisheng Cui, Shengjun Chai, Rui Liu, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12214-12229
Open Access
Genetic heterogeneity and metabolic reprogramming in breast cancer
Yarkın Dolaş, Ayşe Buruş, Başak Çeltikçi
Acta Medica (2024) Vol. 55, Iss. 4, pp. 227-246
Open Access
Hybrid computational modeling highlights reverse Warburg effect in breast cancer-associated fibroblasts
Sahar Aghakhani, Sacha E Silva-Saffar, Sylvain Soliman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top